We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NTI.AU

Price
0.03
Stock movement down
-0.01 (-16.67%)
Company name
Neurotech International Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Medical Devices
Market cap
31.26M
Ent value
19.95M
Price/Sales
-
Price/Book
2.63
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-37.26%
1 year return
-70.00%
3 year return
-13.28%
5 year return
13.40%
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

NTI.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.63
EV to Sales-629.13

FINANCIALS

Per share

Loading...
Per share data
Current share count1.04B
EPS (TTM)-0.01
FCF per share (TTM)-0.01

Income statement

Loading...
Income statement data
Revenue (TTM)-31.71K
Gross profit (TTM)-6.53M
Operating income (TTM)-17.47M
Net income (TTM)-11.45M
EPS (TTM)-0.01
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)20590.82%
Operating margin (TTM)55089.48%
Profit margin (TTM)36101.24%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash11.63M
Net receivables318.05K
Total current assets12.21M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment289.00
Total assets12.21M
Accounts payable278.77K
Short/Current long term debt0.00
Total current liabilities314.70K
Total liabilities314.70K
Shareholder's equity11.90M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-9.69M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-9.69M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-96.22%
Return on Assets-93.75%
Return on Invested Capital-96.22%
Cash Return on Invested Capital-81.41%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.03
Daily high0.03
Daily low0.03
Daily Volume2.51M
All-time high0.42
1y analyst estimate0.60
Beta1.48
EPS (TTM)-0.01
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
NTI.AUS&P500
Current price drop from All-time high-92.81%-17.56%
Highest price drop-99.28%-56.47%
Date of highest drop27 Mar 20209 Mar 2009
Avg drop from high-80.89%-11.07%
Avg time to new high274 days12 days
Max time to new high1901 days1805 days
COMPANY DETAILS
NTI.AU (Neurotech International Ltd) company logo
Marketcap
31.26M
Marketcap category
Small-cap
Description
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found